The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials (ALCHEMIST): Questions and Answers

ALCHEMIST represents three integrated, precision medicine trials that are designed to identify people with early-stage lung cancer who have tumors that harbor certain uncommon genetic changes and evaluate whether drug treatments targeted against those mol


Media Type: Html
  • SourceUrl: https://www.cancer.gov/node/1085893/syndication
  • Syndication ID: 16708
  • Language: English
  • Source: National Cancer Institute (NCI)
  • Date Syndication Captured: Monday, May 22, 2017 at 09:10 PM
  • Date Syndication Updated: Monday, August 05, 2019 at 07:40 PM

Tags

General: treatment trial drug screening lung tumor genetic gene marker mutation ALK EGFR survival ALCHEMIST

Preview   0 Users liked this content.

Embed Code Snippet


To get the embed code snippet please Login.